We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.

Delisted

AMPE was delisted on the 12th of April, 2024.

110 hedge funds and large institutions have $51.5M invested in Ampio Pharmaceuticals Inc. in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more call options, than puts

Call options by funds: $2.19M | Put options by funds: $695K

133% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 15

100% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 9

29% more capital invested

Capital invested by funds: $40M → $51.5M (+$11.5M)

7% more funds holding

Funds holding: 103110 (+7)

Holders
110
Holders Change
+7
Holders Change %
+6.8%
% of All Funds
1.93%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
35
Reduced
15
Closed
9
Calls
$2.19M
Puts
$695K
Net Calls
+$1.49M
Net Calls Change
+$1.18M

AMPE Hedge Fund Activity: Q1 2021 in Review

110 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2021, worth a combined $51.5M — up 29% from $40M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new AMPE positions and 9 closed out — a net gain of 9 holders — while 35 added to existing stakes and 15 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.81M. The largest seller was Group One Trading, cutting an estimated $286K.

  • 110 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2021, up from 103 in Q4 2020.
  • Funds reported $51.5M of Ampio Pharmaceuticals Inc. stock for Q1 2021, up 29% quarter-over-quarter.
  • 18 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2021 and 9 closed out, a net change of +9 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q1 2021 was Millennium Management, an estimated $2.81M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q1 2021 was Group One Trading, an estimated $286K sold.

Based on aggregated 13F filings for Q1 2021.